More intriguingly, upon TGF-β signaling inhibition in breast cancer model, although the numbers of myCAFs and vCAFs decrease, a new subpopulation of CAFs, interferon-licensed CAFs (ilCAFs), appears [107]. The gene discussed is TGFB1; the disease is breast cancer.